Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab

This letter to editor discussing on the publication on immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab. Concerns on confounding factors are raised and discussed.

Detalles Bibliográficos
Autores principales: Joob, Beuy, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782923/
https://www.ncbi.nlm.nih.gov/pubmed/36568997
http://dx.doi.org/10.12998/wjcc.v10.i35.13146
_version_ 1784857454697250816
author Joob, Beuy
Wiwanitkit, Viroj
author_facet Joob, Beuy
Wiwanitkit, Viroj
author_sort Joob, Beuy
collection PubMed
description This letter to editor discussing on the publication on immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab. Concerns on confounding factors are raised and discussed.
format Online
Article
Text
id pubmed-9782923
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-97829232022-12-24 Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab Joob, Beuy Wiwanitkit, Viroj World J Clin Cases Letter to the Editor This letter to editor discussing on the publication on immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab. Concerns on confounding factors are raised and discussed. Baishideng Publishing Group Inc 2022-12-16 2022-12-16 /pmc/articles/PMC9782923/ /pubmed/36568997 http://dx.doi.org/10.12998/wjcc.v10.i35.13146 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Joob, Beuy
Wiwanitkit, Viroj
Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title_full Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title_fullStr Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title_full_unstemmed Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title_short Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
title_sort immunoglobulin g4 associated autoimmune cholangitis and pancreatitis and nivolumab
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782923/
https://www.ncbi.nlm.nih.gov/pubmed/36568997
http://dx.doi.org/10.12998/wjcc.v10.i35.13146
work_keys_str_mv AT joobbeuy immunoglobuling4associatedautoimmunecholangitisandpancreatitisandnivolumab
AT wiwanitkitviroj immunoglobuling4associatedautoimmunecholangitisandpancreatitisandnivolumab

Ejemplares similares